P95 to Merge with South Africa-Based CRO OnQ Research.

MANews-(C)2009-2023

Belgium-based vaccine-focussed CRO P95 BV has merged with South Africa-based CRO OnQ Research (OnQ) to further P95's goal of becoming the global, vaccine-focussed CRO, the company said.

Terms of the transaction were not disclosed.

P95 has expertise conducting research in emerging geographies on the infectious diseases which could possibly drive a future pandemic.

The combined company will continue to offer clinical research services in disease areas beyond its vaccine focus (e.g. oncology, medical devices, cardiology).

Upon completion of the merger, the combined P95-OnQ will have a physical presence in over 30 countries with offices in Europe, Latin America, Asia, and Africa.

Its services...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT